DAILY VERSUS ALTERNATE-DAY ROSUVASTATIN FOR DYSLIPIDEMIA: A RANDOMIZED CONTROLLED STUDY. Int. Res. J. Pharm. 2026, 17 (3), 1-11. https://doi.org/10.56802/e8qzhp89.